Section 1 Short title
This Act may be cited as the “Long-Term Care Pharmacy Definition Act of 2020”.
Long-Term Care Pharmacy Definition Act of 2020
A BILL
To codify a statutory definition for long-term care pharmacies.
Sec. 2 Definition
Section 1860D–2 of the Social Security Act (42 U.S.C. 1395w–102) is amended by adding at the end the following new subsection:
“(f) Long-Term care pharmacy defined
“(1) In general—The term long-term care pharmacy means a pharmacy licensed under applicable State law that is able to provide enhanced pharmacy and clinical services to individuals who require enhanced medication services and reside in a facility (as defined in paragraph (4)).
“(2) Enhanced pharmacy and clinical services—As used in this subsection, the term enhanced pharmacy and clinical services includes—
“(A) medications dispensed pursuant to a prescription or chart order in specialized packaging which shall include unit of use packaging, unit dose packaging, single use containers, packaging from remote automated dispensing technology, or other packaging required;
“(B) drug utilization review to identify potential adverse drug reactions and inappropriate drug usage;
“(C) medication reconciliation services at the transition of care and other necessary clinical management and medication services;
“(D) timely medication delivery 24 hours a day, 7 days a week;
“(E) pharmacist on-call availability to provider dispensing and clinical services 24 hours a day, 7 days a week;
“(F) emergency supplies of medication as permitted by law and as required, including emergency kits or remote automated dispensing technology at a facility; and
“(G) such other services as the Secretary determines appropriate.
“(3) Individuals requiring enhanced medication services—As used in this subsection, the term individual who requires enhanced medication services means an individual who has one or more comorbid and medically complex chronic conditions that are life-threatening or significantly limit overall health or function, pose a high risk of hospitalization or other adverse health outcomes, and require enhanced pharmacy and clinical services.
“(4) Facility—As used in this subsection, the term facility includes a facility described in section 1819(a), 1919(a), or 1905(d), or any other setting in which individuals who require enhanced medication services reside as determined by the Secretary.”